The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Shastry BS. SNPs: impact on gene function and phenotype. Methods Mol. Biol.578,3–22 (2009).
  Medline CASGoogle Scholar
• 2  Slomko H, Heo HJ, Einstein FH. Minireview: epigenetics of obesity and diabetes in humans. Endocrinology153(3),1025–1030 (2012).
  Medline CASGoogle Scholar
• 3  Ugarte M, Brown M, Hollywood KA, Cooper GJ, Bishop PN, Dunn WB. Metabolomic analysis of rat serum in streptozotocin-induced diabetes and after treatment with oral triethylenetetramine (TETA). Genome Med.4(4),35 (2012).
  Medline CASGoogle Scholar
• 4  Lewis GD, Farrell L, Wood MJ et al. Metabolic signatures of exercise in human plasma. Sci. Transl. Med.2(33),33–37 (2010).
  Google Scholar
• 5  Gavaghan CL, Holmes E, Lenz E, Wilson ID, Nicholson JK. An NMR-based metabonomic approach to investigate the biochemical consequences of genetic strain differences: application to the C57BL10J and Alpk:ApfCD mouse. FEBS Lett.484(3),169–174 (2000).
  Medline CASGoogle Scholar
• 6  Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem. Soc. Rev.40(1),387–426 (2011).
  Medline CASGoogle Scholar
• 7  Wishart DS, Knox C, Guo AC et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res.37(Database issue),D603–D610 (2009).
  Medline CASGoogle Scholar
• 8  Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB. Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol.22(5),245–252 (2004).
  Medline CASGoogle Scholar
• 9  Bondia-Pons I, Nordlund E, Mattila I et al. Postprandial differences in the plasma metabolome of healthy Finnish subjects after intake of a sourdough fermented endosperm rye bread versus white wheat bread. Nutr. J.10,116 (2011).
  Medline CASGoogle Scholar
• 10  Pechlivanis A, Kostidis S, Saraslanidis P et al. (1)H NMR-based metabonomic investigation of the effect of two different exercise sessions on the metabolic fingerprint of human urine. J. Proteome Res.9(12),6405–6416 (2010).
  Medline CASGoogle Scholar
• 11  Lloyd AJ, Beckmann M, Fave G, Mathers JC, Draper J. Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption. Br. J. Nutr.106(6),812–824 (2011).
  Medline CASGoogle Scholar
• 12  Oresic M, Simell S, Sysi-Aho M et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to Type 1 diabetes. J. Exp. Med.205(13),2975–2984 (2008).
  Medline CASGoogle Scholar
• 13  Wang TJ, Larson MG, Vasan RS et al. Metabolite profiles and the risk of developing diabetes. Nat. Med.17(4),448–453 (2011).
  Medline CASGoogle Scholar
• 14  Kenny LC, Broadhurst DI, Dunn W et al. Robust early pregnancy prediction of later preeclampsia using metabolomic biomarkers. Hypertension56(4),741–749 (2010).
  Medline CASGoogle Scholar
• 15  Horgan RP, Broadhurst DI, Walsh SK et al. Metabolic profiling uncovers a phenotypic signature of small for gestational age in early pregnancy. J. Proteome Res.10(8),3660–3673 (2011).
  Medline CASGoogle Scholar
• 16  Vermeer LS, Fruhwirth GO, Pandya P, Ng T, Mason AJ. NMR metabolomics of MTLn3E breast cancer cells identifies a role for CXCR4 in lipid and choline regulation. J. Proteome Res.11(5),2996–3003 (2012).
  Medline CASGoogle Scholar
• 17  Catchpole G, Platzer A, Weikert C et al. Metabolic profiling reveals key metabolic features of renal cell carcinoma. J. Cell Mol. Med.15(1),109–118 (2011).
  Medline CASGoogle Scholar
• 18  Brown MV, McDunn JE, Gunst PR et al. Cancer detection and biopsy classification using concurrent histopathological and metabolomic analysis of core biopsies. Genome Med.4(4),33 (2012).
  Medline CASGoogle Scholar
• 19  Loo RL, Chan Q, Brown IJ et al. A comparison of self-reported analgesic use and detection of urinary ibuprofen and acetaminophen metabolites by means of metabonomics: the INTERMAP Study. Am. J. Epidemiol.175(4),348–358 (2012).
  MedlineGoogle Scholar
• 20  Harder U, Koletzko B, Peissner W. Quantification of 22 plasma amino acids combining derivatization and ion-pair LC–MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.879(7–8),495–504 (2011).
  Medline CASGoogle Scholar
• 21  Floegel A, Drogan D, Wang-Sattler R et al. Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach. PLoS ONE6(6),e21103 (2011).▪ One of the first papers assessing the between- and within-person variation observed in serum metabolite concentrations of humans over a 4-month period.
  Medline CASGoogle Scholar
• 22  Dunn WB, Erban A, Weber RJM et al. Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics doi:10.1007/s11306–012–0434–0434 (2012) (Epub ahead of print).
  Google Scholar
• 23  Dunn WB, Broadhurst D, Begley P et al. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat. Protoc.6(7),1060–1083 (2011).▪▪ Describes all technical aspects related to sample preparation, data acquisition and data preprocessing for the investigation of serum or plasma in relation to large-scale studies of the human population.
  Medline CASGoogle Scholar
• 24  Wu H, Xue R, Dong L et al. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry. Anal. Chim. Acta648(1),98–104 (2009).
  Medline CASGoogle Scholar
• 25  Lindon JC, Keun HC, Ebbels TM, Pearce JM, Holmes E, Nicholson JK. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics6(7),691–699 (2005).▪ First paper describing the application of NMR spectroscopy to the study of large sample sets, specifically rodent urine and serum in relation to xenobiotic toxicity.
  Medline CASGoogle Scholar
• 26  Sangster T, Major H, Plumb R, Wilson AJ, Wilson ID. A pragmatic and readily implemented quality control strategy for HPLC–MS and GC–MS-based metabonomic analysis. Analyst131(10),1075–1078 (2006).▪ One of first papers discussing the pragmatic use of QC samples in untargeted metabolomics.
  Medline CASGoogle Scholar
• 27  Want EJ, Wilson ID, Gika H et al. Global metabolic profiling procedures for urine using UPLC–MS. Nat. Protoc.5(6),1005–1018 (2010).▪▪ Describes all technical aspects related to sample preparation, data acquisition and data preprocessing for the investigation of urine in relation to large-scale studies of the human population.
  Medline CASGoogle Scholar
• 28  Feng Z, Prentice R, Srivastava S. Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective. Pharmacogenomics5(6),709–719 (2004).
  Medline CASGoogle Scholar
• 29  Broadhurst DI, Kell DB. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics2(4),171–196 (2006).▪▪ Excellent review discussing the significant issues to consider when performing statistical analysis of untargeted metabolomic datasets.
  CASGoogle Scholar
• 30  Westerhuis JA, Hoefsloot HCJ, Smit S et al. Assessment of PLSDA cross validation. Metabolomics4(1),81–89 (2008).
  CASGoogle Scholar
• 31  Arkin CF, Wachtel MS. How many patients are necessary to assess test performance? JAMA263(2),275–278 (1990).
  Medline CASGoogle Scholar
• 32  Rothman KJ, Greenland S, Lash TL. Modern Epidemiology (3rd Edition). Lippincott Williams & Wilkins, PA, USA (2008).
  Google Scholar
• 33  Teahan O, Gamble S, Holmes E et al. Impact of analytical bias in metabonomic studies of human blood serum and plasma. Anal. Chem.78(13),4307–4318 (2006).
  Medline CASGoogle Scholar
• 34  Dunn WB, Broadhurst D, Ellis DI et al. A GC–TOF–MS study of the stability of serum and urine metabolomes during the UK Biobank sample collection and preparation protocols. Int. J. Epidemiol.37(Suppl. 1),i23–i30 (2008).
  MedlineGoogle Scholar
• 35  Barton RH, Nicholson JK, Elliott P, Holmes E. High-throughput ¹H NMR-based metabolic analysis of human serum and urine for large-scale epidemiological studies: validation study. Int. J. Epidemiol.37(Suppl. 1),i31–i40 (2008).
  MedlineGoogle Scholar
• 36  Zelena E, Dunn WB, Broadhurst D et al. Development of a robust and repeatable UPLC–MS method for the long-term metabolomic study of human serum. Anal. Chem.81(4),1357–1364 (2009).
  Medline CASGoogle Scholar
• 37  Dunn WB, Broadhurst D, Brown M et al. Metabolic profiling of serum using ultra performance liquid chromatography and the LTQ-Orbitrap mass spectrometry system. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.871(2),288–298 (2008).
  Medline CASGoogle Scholar
• 38  US FDA. Guidance for Industry, Bioanalytical Method Validation. US FDA, MD, USA (2001).
  Google Scholar
• 39  Michopoulos F, Lai L, Gika H, Theodoridis G, Wilson I. UPLC–MS-based analysis of human plasma for metabonomics using solvent precipitation or solid phase extraction. J. Proteome Res.8(4),2114–2121 (2009).
  Medline CASGoogle Scholar
• 40  Guo X, Lankmayr E. Phospholipid-based matrix effects in LC–MS bioanalysis. Bioanalysis3(4),349–352 (2011).
  CASGoogle Scholar
• 41  van der Greef J, Martin S, Juhasz Pet al. The art and practice of systems biology in medicine: mapping patterns of relationships. J. Proteome Res.6(4),1540–1559 (2007).▪ One of first papers discussing the application of QC samples in metabolomic studies.
  Medline CASGoogle Scholar
• 42  Veselkov KA, Vingara LK, Masson P et al. Optimized preprocessing of ultra-performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery. Anal. Chem.83(15),5864–5872 (2011).
  Medline CASGoogle Scholar
• 43  Gika HG, Theodoridis GA, Wingate JE, Wilson ID. Within-day reproducibility of an HPLC–MS-based method for metabonomic analysis: application to human urine. J. Proteome Res.6(8),3291–3303 (2007).
  Medline CASGoogle Scholar
• 44  Paglia G, Hrafnsdottir S, Magnusdottir M et al. Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC–Q-ToF-MS). Anal. Bioanal. Chem.402(3),1183–1198 (2012).
  Medline CASGoogle Scholar
• 45  Dunn WB, Brown M, Worton SA et al. The metabolome of human placental tissue: investigation of first trimester tissue and changes related to preeclampsia in late pregnancy. Metabolomics8(4),579–597 (2012).
  CASGoogle Scholar
• 46  van der Kloet FM, Bobeldijk I, Verheij ER, Jellema RH. Analytical error reduction using single point calibration for accurate and precise metabolomic phenotyping. J. Proteome Res.8(11),5132–5141 (2009).
  Medline CASGoogle Scholar
• 47  Kamleh MA, Ebbels TM, Spagou K, Masson P, Want EJ. Optimizing the use of quality control samples for signal drift correction in large-scale urine metabolic profiling studies. Anal. Chem.84(6),2670–2677 (2012).
  Medline CASGoogle Scholar
• 48  Coulier L, Muilwijk B, Bijlsma S et al. Metabolite profiling of small cerebrospinal fluid sample volumes with gas chromatography–mass spectrometry: application to a rat model of multiple sclerosis. Metabolomics doi:10.1007/s11306–012–0428–0422 (2012) (Epub ahead of print).
  MedlineGoogle Scholar
• 49  Xia J, Mandal, R, Sinelnikov IV, Broadhurst D, Wishart DS. MetaboAnalyst 2.0 – a comprehensive server for metabolomic data analysis. Nucleic Acids Res.40(Web Server issue),W127–W133 (2012).
  Google Scholar
• 50  Begley P, Francis-McIntyre S, Dunn WB et al. Development and performance of a gas chromatography-time-of-flight mass spectrometry analysis for large-scale nontargeted metabolomic studies of human serum. Anal. Chem.81(16),7038–7046 (2009).
  Medline CASGoogle Scholar
• 51  Visawanthan C, Bansal S, Booth B et al. Workshop/conference report – quantitative bioanlytical methods validation and implementation: best practices for chromatographic and ligand binding assay. AAPS J.9,E3–E42 (2007).
  Google Scholar
• 101  National Human Tissue Resource Center. http://ndriresource.org
  Google Scholar
• 102  HUSERMET: Human Serum Metabolome in Health and Disease. www.husermet.org
  Google Scholar